Intas B2B Dossier e-portfolio

ā§Ģ āĻšāĻžāϜāĻžā§°+
āĻĄāĻžāωāύāĻ˛â€™āĻĄ
āϏāĻŽāϞ⧰ āĻŽā§‚āĻ˛ā§āϝāĻžāĻ‚āĻ•āύ
āϏāĻ•āϞ⧋
āĻ¸ā§āĻ•ā§ā§°ā§€āύāĻļā§āĻŦāϟ⧰ āĻĒā§āϰāϤāĻŋāĻšā§āĻ›āĻŦāĻŋ
āĻ¸ā§āĻ•ā§ā§°ā§€āύāĻļā§āĻŦāϟ⧰ āĻĒā§āϰāϤāĻŋāĻšā§āĻ›āĻŦāĻŋ
āĻ¸ā§āĻ•ā§ā§°ā§€āύāĻļā§āĻŦāϟ⧰ āĻĒā§āϰāϤāĻŋāĻšā§āĻ›āĻŦāĻŋ
āĻ¸ā§āĻ•ā§ā§°ā§€āύāĻļā§āĻŦāϟ⧰ āĻĒā§āϰāϤāĻŋāĻšā§āĻ›āĻŦāĻŋ
āĻ¸ā§āĻ•ā§ā§°ā§€āύāĻļā§āĻŦāϟ⧰ āĻĒā§āϰāϤāĻŋāĻšā§āĻ›āĻŦāĻŋ
āĻ¸ā§āĻ•ā§ā§°ā§€āύāĻļā§āĻŦāϟ⧰ āĻĒā§āϰāϤāĻŋāĻšā§āĻ›āĻŦāĻŋ
āĻ¸ā§āĻ•ā§ā§°ā§€āύāĻļā§āĻŦāϟ⧰ āĻĒā§āϰāϤāĻŋāĻšā§āĻ›āĻŦāĻŋ
āĻ¸ā§āĻ•ā§ā§°ā§€āύāĻļā§āĻŦāϟ⧰ āĻĒā§āϰāϤāĻŋāĻšā§āĻ›āĻŦāĻŋ
āĻ¸ā§āĻ•ā§ā§°ā§€āύāĻļā§āĻŦāϟ⧰ āĻĒā§āϰāϤāĻŋāĻšā§āĻ›āĻŦāĻŋ

āĻāχ āĻāĻĒā§â€ŒāĻŸā§‹ā§° āĻŦāĻŋāĻˇā§Ÿā§‡

Access to Intas B2B portfolio Global-Dossiers: Biosimilars, Added Value Medicines and Generics.

Access to visual overviews on regulatory information and launch landscape.

Search through our portfolio using filters as stability clime zone, jurisdiction, therapeutic area and more.

Always updated with our last developments, filing plan and available MAs.

All the information also available off-line.
āφāĻĒāĻĄā§‡â€™āϟ āϕ⧰āĻž āϤāĻžā§°āĻŋāĻ–
ā§§ā§Ŧ-ā§Ļā§Ē-⧍ā§Ļ⧍ā§Ē

āĻĄā§‡āϟāĻž āϏ⧁⧰āĻ•ā§āώāĻž

āĻŦāĻŋāĻ•āĻžāĻļāĻ•ā§°ā§āϤāĻžāϏāĻ•āϞ⧇ āφāĻĒā§‹āύāĻžā§° āĻĄā§‡āϟāĻž āϕ⧇āύ⧇āĻ•ā§ˆ āϏāĻ‚āĻ—ā§ā§°āĻš āφ⧰⧁ āĻļā§āĻŦā§‡ā§ŸāĻžā§° āϕ⧰⧇ āĻ¸ā§‡ā§ŸāĻž āĻŦ⧁āϜāĻŋ āĻĒā§‹ā§ąāĻžā§° āϜ⧰āĻŋ⧟āϤ⧇ āϏ⧁⧰āĻ•ā§āώāĻž āφ⧰āĻŽā§āĻ­ āĻšā§ŸāĨ¤ āĻĄā§‡āϟāĻžā§° āĻ—ā§‹āĻĒāĻ¨ā§€ā§ŸāϤāĻž āφ⧰⧁ āϏ⧁⧰āĻ•ā§āώāĻž āĻĒā§ā§°āĻŖāĻžāϞ⧀ āφāĻĒā§‹āύāĻžā§° āĻŦā§āĻ¯ā§ąāĻšāĻžā§°, āĻ…āĻžā§āϚāϞ āφ⧰⧁ āĻŦāϝāĻŧāϏ⧰ āĻ“āĻĒā§°āϤ āĻ­āĻŋāĻ¤ā§āϤāĻŋ āϕ⧰āĻŋ āĻ­āĻŋāĻ¨ā§āύ āĻšâ€™āĻŦ āĻĒāĻžā§°ā§‡āĨ¤ āĻŦāĻŋāĻ•āĻžāĻļāĻ•ā§°ā§āϤāĻžāĻ—ā§°āĻžāĻ•ā§€ā§Ÿā§‡ āĻāχ āϤāĻĨā§āϝāĻ–āĻŋāύāĻŋ āĻĒā§ā§°āĻĻāĻžāύ āϕ⧰āĻŋāϛ⧇ āφ⧰⧁ āϏāĻŽā§Ÿā§° āϞāϗ⧇ āϞāϗ⧇ āĻā§ŸāĻž āφāĻĒāĻĄā§‡â€™āϟ āϕ⧰āĻŋāĻŦ āĻĒāĻžā§°ā§‡āĨ¤
āϤ⧃āĻ¤ā§€ā§Ÿ āĻĒāĻ•ā§āώ⧰ āϏ⧈āϤ⧇ āϕ⧋āύ⧋ āĻĄā§‡āϟāĻž āĻļā§āĻŦ⧇āϝāĻŧāĻžā§° āϕ⧰āĻž āύāĻžāχ
āĻŦāĻŋāĻ•āĻžāĻļāĻ•ā§°ā§āϤāĻžāχ āĻĄā§‡āϟāĻž āĻļā§āĻŦā§‡ā§ŸāĻžā§° āϕ⧰āĻžā§° āĻŦāĻŋāĻˇā§Ÿā§‡ āϕ⧇āύ⧇āĻ•ā§ˆ āĻ˜ā§‹āώāĻŖāĻž āϕ⧰⧇ āϏ⧇āχ āĻŦāĻŋāĻˇā§Ÿā§‡ āĻ…āϧāĻŋāĻ• āϜāĻžāύāĻ•
āĻāχ āĻāĻĒā§â€ŒāĻŸā§‹ā§ąā§‡ āĻāχ āϧ⧰āĻŖā§° āĻĄā§‡āϟāĻž āϏāĻ‚āĻ—ā§ā§°āĻš āϕ⧰āĻŋāĻŦ āĻĒāĻžā§°ā§‡
āĻŦā§āϝāĻ•ā§āϤāĻŋāĻ—āϤ āϤāĻĨā§āϝ
āĻĄā§‡āϟāĻž āĻŸā§ā§°ā§‡āύāϜāĻŋāϟāϤ āĻāύāĻ•ā§ā§°āĻŋāĻĒā§āϟ āϕ⧰āĻž āĻšā§Ÿ
āĻĄā§‡āϟāĻž āĻŽāϚāĻŋāĻŦ āĻ¨ā§‹ā§ąāĻžā§°āĻŋ

āĻāĻĒā§° āϏāĻŽā§°ā§āĻĨāύ

āĻŦāĻŋāĻ•āĻžāĻļāĻ•ā§°ā§āϤāĻžā§° āĻŦāĻŋāĻˇā§Ÿā§‡
INTAS THIRD PARTY SALES 2005 S.L.
ahidalgo@intaspharma.com
CALLE MOLL BARCELONA, S/N 08039 BARCELONA Spain
+34 674 27 85 79